InChI=1S/C20H32O5/c1- 2- 3- 6- 9- 15(21) 12- 13- 17- 16(18(22) 14- 19(17) 23) 10- 7- 4- 5- 8- 11- 20(24) 25/h4,7,16- 18,22H,2- 3,5- 6,8- 14H2,1H3,(H,24,25) /b7- 4- /t16- ,17- ,18+/m1/s1 |
VSRXYLYXIXYEST-KZTWKYQFSA-N |
CCCCCC(=O)CC[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
(5Z,9α)-9-hydroxy-11,15-dioxoprost-5-en-1-oic acid
|
(5Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
|
HMDB
|
(5Z,9alpha)-9-Hydroxy-11,15-dioxoprost-5-en-1-oic acid
|
HMDB
|
(Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
|
HMDB
|
11,15-dioxo-9S-hydroxy-5Z-prostenoic acid
|
LIPID MAPS
|
13,14-dihydro-15-keto-PGD2
|
LIPID MAPS
|
13,14dh,15k-PGD2
|
ChEBI
|
dhk-PGD2
|
LIPID MAPS
|
3004662
|
Reaxys Registry Number
|
Reaxys
|
59894-07-4
|
CAS Registry Number
|
ChemIDplus
|
20671299
|
PubMed citation
|
Europe PMC
|
|